Skip to content

Insider · CIK 0001594408

William H Chang

directorowner

Files at SMLR (Semler Scientific, Inc.). First filing -, latest -.

William H Chang files SEC Form 4 as director and 10% owner at SMLR (Semler Scientific, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; William H Chang has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Dec 9, 2024 SMLR
Semler Scientific, Inc.
10,000
0.14% of outstanding
$618kDec 9, 2024none

Transactions

Every row this insider has filed, 17 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Common Stockindirect: See footnote
-428,682--0Jan 16, 2026
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Common Stockindirect: See footnote
-154,074--0Jan 16, 2026
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Common Stockindirect: See footnote
-241,508--0Jan 16, 2026
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
+4,000$0.00$00Jan 16, 2026
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
+3,560$0.00$00Jan 16, 2026
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
+500$0.00$00Jan 16, 2026
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
+7,125$0.00$00Jan 16, 2026
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
+1,000$0.00$00Jan 16, 2026
Jan 16, 2026SMLR
Semler Scientific, Inc.
DDisposition to issuer
Stock Option (right to buy)derivative
+27,000$0.00$00Jan 16, 2026
Jan 2, 2026SMLR
Semler Scientific, Inc.
AGrant or award
Stock Option (right to buy)derivative
+4,000$0.00$04,000Jan 2, 2026
Dec 15, 2025SMLR
Semler Scientific, Inc.
GGift
Common Stockindirect: see footnote
-60,000$0.00$0428,682Dec 17, 2025
May 2, 2025SMLR
Semler Scientific, Inc.
AGrant or award
Stock Option (right to buy)derivative
+3,560$0.00$03,560May 5, 2025
May 2, 2025SMLR
Semler Scientific, Inc.
AGrant or award
Stock Option (right to buy)derivative
+500$0.00$0500May 5, 2025
Jan 6, 2025SMLR
Semler Scientific, Inc.
AGrant or award
Stock Option (right to buy)derivative
+7,125$0.00$07,125Jan 7, 2025
Jan 6, 2025SMLR
Semler Scientific, Inc.
AGrant or award
Stock Option (right to buy)derivative
+1,000$0.00$01,000Jan 7, 2025
Dec 16, 2024SMLR
Semler Scientific, Inc.
GGift
Common Stockindirect: see footnote
-2,735$0.00$0439,660Dec 17, 2024
Nov 7, 2024SMLR
Semler Scientific, Inc.
AGrant or award
Common Stock
+1,318$0.00$03,500Nov 12, 2024

Questions about William H Chang

Answered from the filings on this page, as of the latest one.

Is William H Chang buying or selling?

William H Chang has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did William H Chang's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William H Chang has 0.

Where does William H Chang file Form 4?

William H Chang has filed Form 4 at SMLR (Semler Scientific, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.